Perth, Australia & Malta – 2 October 2018 – Neurotech International Limited (ASX: NTI) ("Neurotech" or "the Company") is pleased to announce that it has reached another milestone following the submission of its Federal Drug Administration (FDA) clearance application for flagship product Mente Autism.
The Company is seeking clearance for Mente Autism using a de-novo application process and expects the approval process to take 9 – 12 months.
Ann: Mente Autism - FDA Clearance Application, page-2
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NTI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
6.9¢ |
Change
-0.001(1.43%) |
Mkt cap ! $64.55M | |||
| Open | High | Low | Value | Volume |
| 7.1¢ | 7.1¢ | 6.9¢ | $17.85K | 256.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 383058 | 6.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.9¢ | 169928 | 1 |
View Market Depth
| Last trade - 11.36am 29/11/2024 (20 minute delay) ? |
| NTI (ASX) Chart |
